MTech Acquisition Corp. Raises Additional $2.2M
by Kristi Marvin on 2019-06-12 at 9:41am

Overall, MTech has raised $9.2 million in gross proceeds as part of their PIPE.

MTech Acquisition Corp. (MTEC), announced today that they have raised an extra $2.2 million as part of their previously announced private placement.  In this new raise, an additional 215,475 shares of Class A common stock at $10.21 will be issued to new investors along with 23,941 Class B shares (founders shares).

All told, MTech’s will issue a total of 901,074 shares at $10.21 for total gross proceeds of $9.2 million, and 100,119 Class B shares, in this private placement.

Additionally, it was announced that Cresco Capital Partners II, LLC (CCP II), which is an existing investor in MJ Freeway, will be participating in the additional $2.2 million raise. Cresco is a private equity firm, dedicated to investing in the cannabis industry.

MTech’s shareholder vote to approve their business combination is scheduled for Monday, June 17th, and a $9.2 million backstop provides an additional level of comfort.  Stay tuned for any further updates.

 

 

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved